Treating schizophrenia symptoms with an α7 nicotinic agonist, from mice to men

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Biochemical Pharmacology

• Publication date

  2007-10-15

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/J.BCP.2007.07.015
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The Effects of Transdermal Nicotine on Cognition in Nonsmokers with Schizophrenia and Nonpsychiatric Controls

  2008cited by this paper
• SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (II) Efficacy in Experimental Models Predictive of Activity Against Cognitive Symptoms of Schizophrenia

  2007cited by this paper
• α7 Nicotinic Receptor Gene Promoter Polymorphisms in Inbred Mice Affect Expression in a Cell Type-specific Fashion*

  2007cited by this paper
• Cognitive heterogeneity in schizophrenia

  2007cited by this paper
• Proof-of-Concept Trial of an α7 Nicotinic Agonist in Schizophrenia

  2006cited by this paper
• Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationship.

  2006cited by this paper
• A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms.

  2006cited by this paper
• Alpha4beta2 nicotinic receptor stimulation contributes to the effects of nicotine in the DBA/2 mouse model of sensory gating.

  2006cited by this paper
• The neurobiology of cognition in schizophrenia.

  2006cited by this paper
• α4β2 Nicotinic receptor stimulation contributes to the effects of nicotine in the DBA/2 mouse model of sensory gating

  2006cited by this paper
• Tropisetron improves deficits in auditory P50 suppression in schizophrenia.

  2005cited by this paper
• Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.

  2005cited by this paper
• Cognition in schizophrenia: impairments, determinants, and functional importance.

  2005cited by this paper
• Improved p50 auditory gating with ondansetron in medicated schizophrenia patients.

  2005cited by this paper
• Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in alzheimer's disease

  2005cited by this paper
• Nicotine blocks apomorphine‐induced disruption of prepulse inhibition of the acoustic startle in rats: possible involvement of central nicotinic α7 receptors

  2004cited by this paper
• Molecular dissection of tropisetron , an 7 nicotinic acetylcholine receptor-selective partial agonist

  2004cited by this paper
• Clozapine, but not typical antipsychotics, correct P50 suppression deficit in patients with schizophrenia.

  2004cited by this paper
• Nicotine improves delayed recognition in schizophrenic patients

  2004cited by this paper
• Nicotine Improves Sustained Attention in Mice: Evidence for Involvement of the α7 Nicotinic Acetylcholine Receptor

  2004cited by this paper
• Effects of Nicotine on Cognitive Deficits in Schizophrenia

  2004cited by this paper
• Nicotine effects on brain function and functional connectivity in schizophrenia.

  2004cited by this paper
• The promoter −194 C polymorphism of the nicotinic alpha 7 receptor gene has a protective effect against the P50 sensory gating deficit

  2004cited by this paper
• Intravenous nicotine in Alzheimer's disease: a pilot study

  2004cited by this paper
• Safety, Pharmacokinetics, and Effects on Cognitive Function of Multiple Doses of GTS-21 in Healthy, Male Volunteers*

  2003cited by this paper
• Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanism

  2003cited by this paper
• Mecamylamine reversal by nicotine and by a partial alpha7 nicotinic acetylcholine receptor agonist (GTS-21) in rabbits tested with delay eyeblink classical conditioning.

  2003cited by this paper
• DMXB, an α7 nicotinic agonist, normalizes auditory gating in isolation-reared rats

  2003cited by this paper
• Spatial learning in male mice with different levels of aggressiveness: effects of housing conditions and nicotine administration.

  2003cited by this paper
• Attentional effects of nicotinic agonists in rats.

  2003cited by this paper
• Effects of Typical and Atypical Antipsychotics and Receptor Selective Compounds on Acetylcholine Efflux in the Hippocampus of the Rat

  2002cited by this paper
• Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia.

  2002cited by this paper
• Nicotine and Behavioral Markers of Risk for Schizophrenia: A Double-Blind, Placebo-Controlled, Cross-Over Study

  2002cited by this paper
• Effects of alpha 4/beta 2- and alpha 7-nicotine acetylcholine receptor agonists on prepulse inhibition of the acoustic startle response in rats and mice.

  2002influential reference
• Effects of Smoking Abstinence on Visuospatial Working Memory Function in Schizophrenia

  2002cited by this paper
• Effects of Cigarette Smoking and Nicotine Nasal Spray on Psychiatric Symptoms and Cognition In Schizophrenia

  2002cited by this paper
• The effects of nicotine on specific eye tracking measures in schizophrenia.

  2002cited by this paper
• Effects of MK-801 and nicotine combinations on memory consolidation in CD1 mice

  2001cited by this paper
• Evidence for linkage disequilibrium between the alpha 7-nicotinic receptor gene (CHRNA7) locus and schizophrenia in Azorean families.

  2001cited by this paper
• Examination of genetic linkage of chromosome 15 to schizophrenia in a large Veterans Affairs Cooperative Study sample.

  2001cited by this paper
• Influence of cigarette smoking on prepulse inhibition of the acoustic startle response in schizophrenia

  2001cited by this paper
• The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective alpha7 nicotinic receptor partial agonist.

  2001cited by this paper
• Intragastric DMXB-A, an alpha7 nicotinic agonist, improves deficient sensory inhibition in DBA/2 mice.

  2001cited by this paper
• Effects of α4/β2- and α7-nicotine acetylcholine receptor agonists on prepulse inhibition of the acoustic startle response in rats and mice

  2001cited by this paper
• Intragastric DMXB-A, an α7 nicotinic agonist, improves deficient sensory inhibition in DBA/2 mice

  2001cited by this paper
• Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia.

  2001cited by this paper
• Suggestive evidence for linkage of schizophrenia to markers at chromosome 15q13-14 in Taiwanese families.

  2001cited by this paper
• A nicotinic cholinergic agonist (GTS-21) and eyeblink classical conditioning: acquisition, retention, and relearning in older rabbits.

  2000cited by this paper
• Development of nicotinic drug therapy for cognitive disorders.

  2000cited by this paper
• (-)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidin-2'-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptor.

  2000cited by this paper
• Haplotype transmission disequilibrium and evidence for linkage of the CHRNA7 gene region to schizophrenia in Southern African Bantu families.

  2000cited by this paper
• Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

  2000cited by this paper
• α7 Receptor-selective agonists and modes of α7 receptor activation

  2000cited by this paper
• Role of a 7 nicotinic receptors in nicotine dependence and implications for psychiatric illness

  2000cited by this paper
• Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task.

  2000cited by this paper
• Smoking and mental illness: A population-based prevalence study.

  2000cited by this paper
• Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer’s disease

  1999cited by this paper
• Nicotine Withdrawal and Psychiatric Symptoms in Cigarette Smokers with Schizophrenia

  1999cited by this paper
• Evidence for bilineal inheritance of physiological indicators of risk in childhood-onset schizophrenia.

  1999cited by this paper
• Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia I: sensitivity, reliability, and validity.

  1999cited by this paper
• No evidence for linkage between schizophrenia and markers at chromosome 15q13-14.

  1999cited by this paper
• Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland.

  1999cited by this paper
• Auditory P50 in Schizophrenics on Clozapine: Improved Gating Parallels Clinical Improvement and Changes in Plasma 3-Methoxy-4-Hydroxyphenylglycol

  1999cited by this paper
• Smoking and therapeutic response to clozapine in patients with schizophrenia.

  1999cited by this paper
• Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain.

  1999cited by this paper
• Selective alpha 7 nicotinic receptor stimulation normalizes chronic cocaine-induced loss of hippocampal sensory inhibition in C3H mice.

  1999cited by this paper
• Neuronal Nicotinic Receptors in Dementia with Lewy Bodies and Schizophrenia

  1999cited by this paper
• Nicotine improves memory in an object recognition task in rats.

  1999cited by this paper
• Poor P50 suppression among schizophrenia patients and their first-degree biological relatives.

  1998cited by this paper
• Nicotine safety and toxicity

  1998cited by this paper
• Contribution of nicotinic receptors to the function of synapses in the central nervous system: The action of choline as a selective agonist of α7 receptors

  1998cited by this paper
• Nicotinic acetylcholine involvement in cognitive function in animals

  1998cited by this paper
• Analysis of 3-(4-hydroxy, 2-Methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors.

  1998cited by this paper
• Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disorders.

  1998cited by this paper
• No evidence for linkage of the CHRNA7 gene region in Canadian schizophrenia families.

  1998cited by this paper
• Smoking and cognitive deficits in schizophrenia: a pilot study.

  1998cited by this paper
• Contribution of nicotinic receptors to the function of synapses in the central nervous system: the action of choline as a selective agonist of alpha 7 receptors.

  1998cited by this paper
• Acetylcholine Activates an α-Bungarotoxin-Sensitive Nicotinic Current in Rat Hippocampal Interneurons, But Not Pyramidal Cells

  1998cited by this paper
• Selective α7-nicotinic agonists normalize inhibition of auditory response in DBA mice

  1998cited by this paper
• Further investigation of a chromosome 15 locus in schizophrenia: analysis of affected sibpairs from the NIMH Genetics Initiative.

  1998cited by this paper
• Nicotinic receptor desensitization and sensory gating deficits in schizophrenia.

  1998cited by this paper
• Protective effect of GTS-21, a novel nicotinic receptor agonist, on delayed neuronal death induced by ischemia in gerbils.

  1998cited by this paper
• 3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat α7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner

  1997cited by this paper
• Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo.

  1997cited by this paper
• Normalizing effects of nicotine and a novel nicotinic agonist on hippocampal auditory gating in two animal models.

  1997cited by this paper
• P50 suppression among schizophrenia and normal comparison subjects: a methodological analysis.

  1997cited by this paper
• Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors.

  1997cited by this paper
• Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers.

  1997cited by this paper
• Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus.

  1997cited by this paper
• Genetic Correlation of Inhibitory Gating of Hippocampal Auditory Evoked Response and α-Bungarotoxin-Binding Nicotinic Cholinergic Receptors in Inbred Mouse Strains

  1996cited by this paper
• Nicotine–Haloperidol Interactions and Cognitive Performance in Schizophrenics

  1996cited by this paper
• Increased regional cerebral glucose metabolism and semantic memory performance in Alzheimer's disease: A pilot double blind transdermal nicotine positron emission tomography study

  1996cited by this paper
• Replication of a P50 auditory gating deficit in Australian patients with schizophrenia.

  1996cited by this paper
• Smoking, smoking withdrawal and schizophrenia: case reports and a review of the literature.

  1996cited by this paper
• Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21.

  1995cited by this paper
• Nicotine dependence, midbrain dopamine systems and psychiatric disorders.

  1995cited by this paper
• GABAB antagonists diminish the inhibitory gating of auditory response in the rat hippocampus.

  1995cited by this paper
• Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia.

  1995cited by this paper
• Human alpha 7 nicotinic acetylcholine receptor responses to novel ligands.

  1995cited by this paper
• Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes.

  1995cited by this paper

• Magnesium and Zinc in Schizophrenia

  2025cites this paper
• Vagus nerve SARS‐CoV‐2 infection and inflammatory reflex dysfunction: Is there a causal relationship?

  2023cites this paper
• A selective literature review exploring the role of the nicotinic system in schizophrenia

  2023cites this paper
• An α7 nAChR approach for the baseline-dependent modulation of deviance detection in schizophrenia: A pilot study assessing the combined effect of CDP-choline and galantamine

  2023cites this paper
• Homomeric and Heteromeric α7 Nicotinic Acetylcholine Receptors in Health and Some Central Nervous System Diseases

  2021cites this paper
• Constructing 24/7 Madness. The Pathology Behind Schizophrenia in Western Urban Screen Cultures

  2020cites this paper
• Pharmacologic Modulation of Hippocampal Activity in Psychosis

  2020cites this paper
• The role of nicotinic cholinergic neurotransmission in delusional thinking

  2020cites this paper
• Microglia in the developing prefrontal cortex of rats show dynamic changes following neonatal disconnection of the ventral hippocampus

  2019cites this paper
• The relationship between nicotine and psychosis

  2019cites this paper
• Combining CDP-choline and galantamine, an optimized α7 nicotinic strategy, to ameliorate sensory gating to speech stimuli in schizophrenia.

  2019cites this paper
• Chromosome 15q13.3 microduplications are associated with treatment refractory major depressive disorder

  2019cites this paper
• Experimental Medicine Approaches in CNS Drug Development

  2019cites this paper
• Assessing the acute effects of CDP-choline on sensory gating in schizophrenia: A pilot study

  2018cites this paper
• Cholinergic Protection in Ischemic Brain Injury

  2017cites this paper
• Single-Cell Profiling of an In Vitro Model of Human Interneuron Development Reveals Temporal Dynamics of Cell Type Production and Maturation.

  2017cites this paper
• New Targets for Schizophrenia Treatment beyond the Dopamine Hypothesis

  2017cites this paper
• Short- and long-term effects of nicotine and the histone deacetylase inhibitor phenylbutyrate on novel object recognition in zebrafish

  2017cites this paper
• New drug developments in psychosis: Challenges, opportunities and strategies

  2017cites this paper
• Étude des mécanismes de contrôle cognitif sous-tendant les détériorations et fluctuations d'attention soutenue chez les patients souffrant de schizophrénie et les sujets sains

  2017cites this paper
• Screening of Cognitive Impairment in Schizophrenia

  2016cites this paper
• Design of α7 nicotinic acetylcholine receptor ligands using the (het)Aryl-1,2,3-triazole core: Synthesis, in vitro evaluation and SAR studies.

  2016cites this paper
• Neuropharmacology of altered brain oscillations in schizophrenia.

  2016cites this paper
• nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.

  2016cites this paper
• Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia.

  2016cites this paper
• Acetylcholinergic Nicotinic Receptors as Pharmacological Targets for Cognitive Enhancement: Emerging Evidence from Psychosis Populations

  2016cites this paper
• The antiepileptic drug levetiracetam improves auditory gating in DBA/2 mice

  2015cites this paper
• Maximizing the effect of an α7 nicotinic receptor PAM in a mouse model of schizophrenia-like sensory inhibition deficits.

  2015cites this paper
• Brain in flames – animal models of psychosis: utility and limitations

  2015cites this paper
• Central Nervous System Modulators from the Oceans

  2015cites this paper
• Dementia praecox redux: A systematic review of the nicotinic receptor as a target for cognitive symptoms of schizophrenia

  2015cites this paper
• Effects of a ketogenic diet on auditory gating in DBA/2 mice: A proof-of-concept study.

  2015cites this paper
• Clozapine improves the orienting of attention in schizophrenia.

  2015cites this paper
• Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker

  2015cites this paper
• Translational utility of rodent hippocampal auditory gating in schizophrenia research: a review and evaluation

  2015cites this paper
• Neurocognitive effects of acute choline supplementation in low, medium and high performer healthy volunteers.

  2015cites this paper
• α7 nicotinic ACh receptor‐deficient mice exhibit sustained attention impairments that are reversed by β2 nicotinic ACh receptor activation

  2015cites this paper
• Cellular, molecular, and genetic substrates underlying the impact of nicotine on learning.

  2014cites this paper
• Allosteric Modulation as a Therapeutic Alternative to Orthosteric Activation in Nicotinic Acetylcholine Receptors

  2014cites this paper
• Chapter 5 - Bioassays for Bioactivity Screening

  2014cites this paper
• Diversity of Conus peptides that target the nicotinic acetylcholine receptors

  2013cites this paper
• Baseline dependency of nicotine’s sensory gating actions: similarities and differences in low, medium and high P50 suppressors

  2013cites this paper
• Intermittent versus continuous central administration of clozapine in DBA/2 mice, improvement in sensory inhibition deficits.

  2013cites this paper
• Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: a proof-of-mechanism study.

  2013cites this paper
• A Randomized Exploratory Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) for Cognitive Enhancement in Schizophrenia

  2013cites this paper
• A positive allosteric modulator of α7 nAChRs augments neuroprotective effects of endogenous nicotinic agonists in cerebral ischaemia

  2013cites this paper
• Modulowanie funkcji układu cholinergicznego w leczeniu schizofrenii – dziś i jutro

  2013cites this paper
• Effects of an Alpha7 Nicotinic Receptor Agonist and Stress on Spatial Memory in an Animal Model of Alzheimer's Disease

  2013cites this paper
• α7-Containing nicotinic acetylcholine receptors on interneurons of the basolateral amygdala and their role in the regulation of the network excitability.

  2013cites this paper
• Nicotine Restores Wt-Like Levels of Reelin and GAD67 Gene Expression in Brain of Heterozygous Reeler Mice

  2013cites this paper
• A Type-II Positive Allosteric Modulator of α7 nAChRs Reduces Brain Injury and Improves Neurological Function after Focal Cerebral Ischemia in Rats

  2013cites this paper
• Leveraging the cortical cholinergic system to enhance attention.

  2013cites this paper
• Chaperoning α7 neuronal nicotinic acetylcholine receptors.

  2012cites this paper
• Nicotine, Auditory Sensory Memory, and sustained Attention in a Human Ketamine Model of Schizophrenia: Moderating Influence of a Hallucinatory Trait

  2012cites this paper
• Unusual Effects of Nicotine as a Psychostimulant on Ambulatory Activity in Mice

  2012cites this paper
• Cotinine: Beyond that Expected, More than a Biomarker of Tobacco Consumption

  2012cites this paper
• [3H]Chiba‐1001(methyl‐SSR180711) has low in vitro binding affinity and poor in vivo selectivity to nicotinic alpha‐7 receptor in rodent brain

  2012cites this paper
• Clinically Important Differences in the Pharmacokinetics of the Ten Newer “Atypical” Antipsychotics: Part 2. Metabolism and Elimination

  2012cites this paper
• Mouse models for studying genetic influences on factors determining smoking cessation success in humans

  2012cites this paper
• Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia.

  2012cites this paper
• α7 nicotinic ACh receptors as a ligand-gated source of Ca(2+) ions: the search for a Ca(2+) optimum.

  2012cites this paper
• Cotinine: A Potential New Therapeutic Agent against Alzheimer's disease

  2012cites this paper
• Schizophrenia and the immune system: pathophysiology, prevention, and treatment.

  2012cites this paper
• Psychopharmacological treatment of schizophrenia: what do we have, and what could we get?

  2012cites this paper
• Effects of the Novel α7 Nicotinic Acetylcholine Receptor Agonist ABT-107 on Sensory Gating in DBA/2 Mice: Pharmacodynamic Characterization

  2012cites this paper
• Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits.

  2012cites this paper
• Stress and the α7 nicotinic acetylcholine receptor.

  2012cites this paper
• Cholinergic contributions to the cognitive symptoms of schizophrenia and the viability of cholinergic treatments.

  2012cites this paper
• Nicotinic receptor activation in perirhinal cortex and hippocampus enhances object memory in rats.

  2012cites this paper
• Chaperoning a7 neuronal nicotinic acetylcholine receptors

  2012cites this paper
• Neuroimaging Modalities: Description, Comparisons, Strengths, and Weaknesses

  2012cites this paper
• Activation, desensitization and potentiation of alpha7 nicotinic acetylcholine receptors: Relevance to alpha7-targeted therapeutics

  2012cites this paper
• 3‐(2,4‐Dimethoxybenzylidene)‐anabaseine: A promising candidate drug for Alzheimer's disease?

  2012cites this paper
• Effects of α7 nicotinic acetylcholine receptor agonists on antipsychotic efficacy in a preclinical mouse model of psychosis

  2011cites this paper
• Occupancy of α7 Nicotinic Acetylcholine Receptors in the Brain by Tropisetron: A Positron Emission Tomography Study Using [11C]CHIBA-1001 in Healthy Human Subjects

  2011cites this paper
• Separate and combined effects of low dose ketamine and nicotine on behavioural and neural correlates of sustained attention.

  2011cites this paper
• Synthesis of bridgehead-substituted azabicyclo[2.2.1]heptane and -[3.3.1]nonane derivatives for the elaboration of α7 nicotinic ligands.

  2011cites this paper
• Aligning strategies for using EEG as a surrogate biomarker: a review of preclinical and clinical research.

  2011cites this paper
• Behavioral effects of PNU-282987, an alpha7 nicotinic receptor agonist, in mice.

  2011cites this paper
• Nicotine ameliorates NMDA receptor antagonist-induced deficits in contextual fear conditioning through high-affinity nicotinic acetylcholine receptors in the hippocampus.

  2011cites this paper
• Natural products: an evolving role in future drug discovery.

  2011cites this paper
• Pre-clinical validation of a novel alpha-7 nicotinic receptor radiotracer, [(3)H]AZ11637326: target localization, biodistribution and ligand occupancy in the rat brain.

  2011cites this paper
• Electrophysiological Perspectives on the Therapeutic Use of Nicotinic Acetylcholine Receptor Partial Agonists

  2011cites this paper
• P50 sensory gating and smoking in the general population

  2011cites this paper
• From 'classical' antipsychotics to 'multidimensional stabilizers': do we need a new classification for novel drugs used in schizophrenia?

  2011cites this paper
• Les effets d’un traitement chronique aux antipsychotiques sur la poursuite d’une récompense conditionnée

  2011cites this paper
• Involvement of the cholinergic system in conditioning and perceptual memory.

  2011cites this paper
• In Search of Allosteric Modulators of α7-nAChR by Solvent Density Guided Virtual Screening

  2011cites this paper
• History of Antipsychotic Drug Development

  2011cites this paper
• Natural Products in Drug Discovery: Impacts and Opportunities — An Assessment

  2011cites this paper
• Marine Organisms and Their Prospective Use in Therapy of Human Diseases

  2011cites this paper
• Acute Nicotine Alteration of Sensory Memory Impairment in Smokers With Schizophrenia

  2010cites this paper
• Smoking, nicotine and neuropsychiatric disorders.

  2010cites this paper
• A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia

  2010cites this paper
• MODULATION OF THE ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR FOLLOWING EXPERIMENTAL RAT BRAIN INJURY IMPROVES CELLULAR AND BEHAVIORAL OUTCOMES

  2010cites this paper
• Physiological Concentrations of Choline Activate Native α7-Containing Nicotinic Acetylcholine Receptors in the Presence of PNU-120596 [1-(5-Chloro-2,4-dimethoxyphenyl)-3-(5-methylisoxazol-3-yl)-urea]

  2010cites this paper
• The role of nicotine on respiratory sensory gating measured by respiratory-related evoked potentials.

  2010cites this paper
• α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer’s Disease

  2010cites this paper
• Characterization of [(3)H]CHIBA-1001 binding to alpha7 nicotinic acetylcholine receptors in the brain from rat, monkey, and human.

  2010cites this paper
• The odyssey of marine pharmaceuticals: a current pipeline perspective.

  2010cites this paper